aeruginosa infections and rejection of transplanted lungs, but a possible solution for the problem. More information: Fuyi ...
5mon
News Medical on MSNUnraveling the survival strategies of Pseudomonas aeruginosa in lung infectionsThat's what the bacterium Pseudomonas aeruginosa faces when ... antibiotic-resistant infections, causing damage especially in ...
The Foundation’s funding will support Owlstone Medical’s development of a breath test to help doctors diagnose and monitor ...
Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...
Saccharin, the artificial sweetener used in diet foods like yogurts and sugar-free drinks, can kill multidrug-resistant ...
Vast Therapeutics, a clinical-stage life science company, today announced that the U.S. Food and Drug Administration has ...
Some notoriously difficult to treat infections may not be as resistant to antibiotics as has been thought, according to new research using a microfluidic device that more closely duplicates the fluid ...
17don MSN
Some notoriously difficult-to-treat infections may not be as resistant to antibiotics as has been thought, according to new ...
Aztreonam for inhalation solution is approved by the FDA to improve respiratory symptoms in patients with cystic fibrosis with P. aeruginosa infection 6. Analysing issues in the treatment of ...
6d
News-Medical.Net on MSNOwlstone Medical secures investment from Cystic Fibrosis Foundation("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that the Cystic Fibrosis Foundation has made an up to USD $2.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results